Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9BTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,540
Award facts
- Contract value 100% obligated
- $32,539.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,539.56 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of December 19, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle enabling the company to supply pharmaceuticals and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor within the federal medical procurement landscape through multiple competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio demonstrates versatility in fulfilling federal medical supply requirements across diverse therapeutic domains, ranging from specialty medications to generic pharmaceuticals and medical devices. This particular delivery order for DESCOVY, an antiviral medication, reflects the company's ongoing role in supporting military and veteran healthcare systems with pharmaceutical products essential to federal health programs.
Quick answers
Who was awarded contract SPE2DR26F9BTU?
SPE2DR26F9BTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9BTU worth?
The government has obligated $32,540 on SPE2DR26F9BTU.
Is contract SPE2DR26F9BTU an order under another contract?
Yes. SPE2DR26F9BTU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BTU competed?
The extent of competition for SPE2DR26F9BTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award